Loading clinical trials...
Loading clinical trials...
Phase 1, open-label study of BHV-0223 in ALS.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Biohaven Pharmaceuticals, Inc.
Collaborators
NCT07587476 · Cerebral Palsy (CP)
NCT06280079 · Amyotrophic Lateral Sclerosis
NCT06051123 · ALSFTD, ALS (Amyotrophic Lateral Sclerosis), and more
NCT01829724 · Cerebral Palsy, Children
NCT06498596 · Cerebral Palsy
Holy Cross Neuroscience Research Institute
Fort Lauderdale, Florida
Somnos/Neurology Associates Clinical Research
Lincoln, Nebraska
Neurosciences Institute, Neurology - Charlotte
Charlotte, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions